Myocardial perfusion abnormalities in chemical warfare patients intoxicated with mustard gas

International Journal of Cardiovascular Imaging

Volumn 23, Issue 2, 2007, Pages 197-205

  Gholamrezanezhad, Ali ^a,b   Saghari, Mohsen ^a   Vakili, Arsalan ^a   Mirpour, Sahar ^a   Farahani, Mohammad Hossein ^c  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b ISLAMIC AZAD UNIVERSITY   (Iran)

^c Nuclear Medicine Department   (Iran)

Author keywords

99mTc sestamibi; Chemical warfare; Mustard agents; Myocardial perfusion scintigraphy

Indexed keywords

AMINOPHYLLINE; DIPYRIDAMOLE; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; MUSTARD GAS;

ADULT; ARTICLE; CHEMICAL WARFARE; CLINICAL ARTICLE; CONTROLLED STUDY; DIZZINESS; EXERCISE TEST; FEMALE; GAS POISONING; HEADACHE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE HYPERTROPHY; HEART MUSCLE ISCHEMIA; HEART MUSCLE PERFUSION; HEART RIGHT VENTRICLE EJECTION FRACTION; HEART SCINTISCANNING; HEART VENTRICLE SIZE; HUMAN; HYPERTENSION; HYPOTENSION; IMAGE RECONSTRUCTION; MALE; PHARMACOLOGIC STRESS TESTING; QUANTITATIVE ANALYSIS; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; THORAX PAIN;

EID: 33947222604     PISSN: 15695794     EISSN: 18758312     Source Type: Journal    
DOI: 10.1007/s10554-006-9122-7     Document Type: Article

References (46)

1. Khateri S, Ghanei M, Keshavarz S, Soroush M, Haines D (2003) Incidence of lung, eye, and skin lesions as late complications in 34,000 Iranians with wartime exposure to mustard agent. J Occup Environ Med 45: 1136-1143
2. U.S Army Field Manual 3-9, U.S. Navy Publication P-467, U.S. Air Force Manual 355-7, "Potential Military Chemical/Biological Agents and Compounds," Washington DC; 1990
3. Federation of American Scientists Report: "Special Weapons Primer." October 21, 1998. Adapted from Chemical Weapons Technology Militarily Critical Technologies list (MCTL) Part II: Weapons of Mass Destruction Technologies. From: FM 8-9, NATO Handbook on the Medical Aspects of NBC Defensive of the Army, the Navy and Air Force, Washington DC; 1996
4. United Nation official reports S/16433(1984), S/17911(1986), and S/ 18852(1987)
5. Statistic Annals Booklet of the Janbazan Organization (2000) Clinical status of chemical warfare victims. Janbazan Organization, Health and Treatment Department
6. Forootan A (1996) Medical notes on the chemical warfare: Part I. Kowsar Med J 1:91-97
7. Thomsen AB, Eriksen J, Smidt-Nielsen K (1998) Chronic neuropathic symptoms after exposure to mustard gas: A long-term investigation. J Am Acad Dermatol 39:187-190
8. Norman J (1975) Lung cancer mortality in World War I veterans with mustard-gas injury: 1919-1965. J Natl Cancer Inst 54:311-317
9. Yamakido M, Ishioka S, Hiyama K et al (1996) Former poison gas workers and cancer: Incidence and inhibition of tumor formation by treatment with biological response modifier N-CWS. Environ Health Perspect 104(suppl 3):485-488
10. Easton DF, Peto J, Doll R (1988) Cancers of the respiratory tract in mustard gas workers. Br J Indust Med 45:652-659
11. Nishimoto Y, Yamakido M, Ishioka S et al (1987) Epidemiological studies of lung cancer in Japanese mustard gas workers. Princess Takamatsu Symp 18: 95-101
12. Tokuoka S, Hayashi Y, Inai K et al (1986) Early cancer and related lesions in the bronchial epithelium in former workers of mustard gas factory. Acta Pathol Jpn 36:533-542
13. Nishimoto Y, Yamakido M, Shigenobu T et al (1983) Long-term observation of poison gas workers with special reference to respiratory cancers. J UOEH 20(suppl):89-94
14. Manning KP, Skegg DC, Stell PM et al (1981) Cancer of the larynx and other occupational hazards of mustard gas workers. Clin Otolaryngol 63:165-170
15. Azizi F, Keshavarz A, Roshanzamir F et al (1995) Reproductive function in men following exposure to chemical warfare with sulfur mustard. Med War 11:34-44
16. Safarinejad MR, Moosavi SA, Montazeri B (2001) Ocular injuries caused by mustard gas: Diagnosis, treatment, and medical defense. Mil Med 166:67-70
17. Pleyer U, Sherif Z, Baatz H et al (1999) Delayed mustard gas keratopathy: Clinical findings and confocal microscopy. Am J Ophthalmol 128:506-507
18. Dahl H, Gluud B, Vangsted P et al (1985) Eye lesions induced by mustard gas. Acta Ophthalmol Suppl 173:30-31
19. Balali M (1984) Clinical and laboratory findings in Iranian fighters with chemical gas poisoning. Arch Belg Suppl:254-259
20. Asboe S, Fledelius H (1978) Mustard gas: A medical-ecological problem. Eye and skin injuries in 3 Ostersjo fishermen. Ugeskr Laeger 140:2048-2050
21. Geeraets WJ, Abedi S, Blanke RV (1977) Acute corneal injury by mustard gas. South Med J 70:348-350
22. Blodi FC (1971) Mustard gas keratopathy. Int Ophthalmol Clin 11:1-13
23. Momeni AZ, Aminjavaheri M (1994) Skin manifestations of mustard gas in a group of 14 children and teenagers: A clinical study. Int J Dermatol 33: 184-187
24. Bullman T, Kang HA (2000) Fifty year mortality follow-up study of veterans exposed to low level chemical warfare agent, mustard gas. Ann Epidemiol 10:333-338
25. Olajos EJ, Olson CT, Salem H et al (1998) Evaluation of neutralized chemical agent identification sets (CAIS) for skin injury with an overview of the vesicant potential of agent degradation products. J Appl Toxicol 18:409-420
26. Petrali JP, Oglesby-Megee S (1997) Toxicity of mustard gas skin lesions. Microsc Res Technol 37:221-228
27. Smith KJ, Hurst CG, Moeller RB et al (1995) Sulfur mustard: Its continuing threat as a chemical warfare agent, the cutaneous lesions induced, progress in understanding its mechanism of action, its long-term health effects, and new developments for protection and therapy. J Am Acad Dermatol 32:765-776
28. Ghanei M (2001) Late Pulmonary Complications of Mustard Gas Inhalation. Abstract B2, World Congress on Chemical and Biological Terrorism; Dubrovnic, Croatia; April 23-27
29. Aslani J, Ghanei M (1998) A case of unilateral lung collapse in a mustard gas victim. Mil Med 1:49-50
30. Emad A, Rezaian GR (1997) The diversity of the effects of sulfur mustard gas inhalation on respiratory system 10 years after a single, heavy exposure: Analysis of 197 cases. Chest 112:734-738
31. Assennato G, Ambrosi F, Sivo D (1997) Possible long-term effects on the respiratory system of exposure to yperite of fishermen. Med Lav 88:148-154
32. Andrew DJ, Lindsay CD (1998) Protection of human upper respiratory tract cell lines against sulfur mustard toxicity by hexamethylenetetramine (HMT). Hum Exp Toxicol 17:373-379
33. Anderson DR, Byers SL, Vesely KR (2000) Treatment of sulfur mustard (HD)-induced lung injury. J Appl Toxicol 20(suppl 1):S129-S132
34. Rappeneau S, Baeza-Squiban A, Marano F et al (2000) Efficient protection of human bronchial epithelial cells against sulfur and nitrogen mustard cytotoxicity using drug combinations. Toxicol Sci 58:153-160
35. Emad A, Rezaian GR (1999) Immunoglobulins and cellular constituents of the BAL fluid of patients with sulfur mustard gas induced pulmonary fibrosis. Chest 115:1346-1351
36. Calvet JH, Planus E, Rouet P et al (1999) Matrix metalloproteinase gelatinases in sulfur mustard-induced acute airway injury in guinea pigs. Am J Physiol 276:L754-L762
37. Calvet JH, Gascard JP, Delamanche S et al (1999) Airway epithelial damage and release of inflammatory mediators in human lung parenchyma after sulfur mustard exposure. Hum Exp Toxicol 18:77-81
38. Langford AM, Hobbs MJ, Upshall DG et al (1996) The effect of sulfur mustard on glutathione levels in rat lung slices and the influence of treatment with arylthiols and cysteine esters. Hum Exp Toxicol 15:619-624
39. D'Agostino RB Sr, Grundy S, Sullivan LM, Wilson P (2001) CHD Risk Prediction Group. Validation of the Framingham coronary heart disease prediction scores: Results of a multiple ethnic groups investigation. JAMA 286:180-187
40. Roberti RR, Van Tosh A, Baruchin MA et al (1994) Left ventricular cavity-to-myocardial count ratio: A new parameter for detecting resting left ventricular dysfunction directly from tomographic thallium perfusion scintigraphy. J Nucl Med 34:193-198
41. Saidova MA, Ostroumov EN, Naumov VG, Sergienko VB, Belenkov IuN (1992) The radionuclide diagnosis of dilated cardiomyopathy: A new approach to assessing myocardial perfusion function by 201Tl scintigraphic data at rest and during the performance of the dipyridamole test. Kardiologiia 32(7-8):50-55
42. Li PC, Sun SS, Kao A, Lin CC, Lee CC (2002) Left ventricular cavity-to-myocardium count ratio in exercise and resting technetium-99 m-tetrofosmin SPECT: Correlation with left ventricular function. Int J Cardiovasc Imaging 18(5):349-352
43. Sciagra R, Bisi G, Buonamici P, Zerauschek F, Santoro GM, Meldolesi U, Fazzini PF, Pupi A (1997) Left ventricular cavity-to-myocardium count ratio in technetium-99 m-sestamibi SPECT in the detection of resting left ventricular dysfunction. J Nucl Med 38(5):766-770
44. Maunoury C, Antonietti T, Sebahoun S, Barritault L (2001) Assessment of left ventricular function by 201Tl SPECT using left ventricular cavity-to-myocardium count ratio. Nucl Med Commun 22(3):281-285
45. Singer AW, Jaax NK, Graham JS, McLeod CG Jr (1987) Cardiomyopathy in Soman and Sarin intoxicated rats. Toxicol Lett 36(3):243-249
46. Ding HJ, Lin CC, Wang JJ, Ho ST, Kao A (2002) Correlation of abnormal response of left ventricular ejection fraction after exercise and left ventricular cavity-to-myocardium count ratio of technetium-99 m-tetrofosmin single photon emission computed tomography in patients with coronary artery disease. Jpn Heart J 43(5):505-514